#Canada #Vancouver #VSDHOne #Hydreight #Victory Square

Victory Square Technologies Reports Robust Growth in Fiscal Year 2025

Victory Square Technologies Inc. continues to gain momentum as it navigates through fiscal year 2025 with impressive performance metrics. The company, known for its focus on healthcare infrastructure and digital health services, recently disclosed its financial results, which underscore the significant growth across its platforms, particularly through its flagship subsidiary, Hydreight Technologies Inc.

In a year characterized by expansion and innovation, Victory Square achieved a remarkable $35.4 million in revenue, a significant leap from the $16.04 million recorded in 2024. This 121% year-over-year growth reflects the rapid adoption and scaling of its digital health offerings. Such success can be attributed to the increasing utilization of the Hydreight platform, which has become a cornerstone of the company’s growth trajectory.

Building Towards Success

Shafin Diamond Tejani, the Chairman and CEO of Victory Square, shared insights on the company's strategic direction, emphasizing the importance of building scalable systems. He stated, “For years, we've been constructing infrastructure in complex, high-value markets. In 2025, we began to witness that infrastructure translate into real scale — revenue growth, profitability, and increased visibility into what these platforms can become.” This sentiment captures the essence of Victory Square's operations, which focus on establishing robust pathways for healthcare delivery amidst evolving market demands.

The financial highlights provide further insights into the company's operational efficiency and growing market presence:

• - Adjusted Revenue reached approximately $43.56 million.
• - Adjusted EBITDA soared to $2.5 million, a staggering increase of 1,765% from the previous fiscal year.
• - The company’s cash and marketable securities totaled $22 million, showcasing a solid financial base to support continued growth.
• - Total expenses decreased to $9.3 million, aided by enhanced operational efficiencies and disciplined cost management.

Victory Square’s commitment to operating leverage is evident as operating expenses dropped significantly as a percentage of revenue from 38% in 2024 to just 22% in 2025. This allowed the company to improve margins while effectively scaling the Hydreight platform.

Hydreight: Proof of Concept

As Victory Square's largest operating subsidiary, Hydreight Technologies stands as a testament to the company’s successful strategy. The platform facilitates compliant healthcare delivery across the United States, covering a wide spectrum of services including GLP-1 therapies and wellness programs. The company reported remarkable platform activity, with over 11,000 licenses signed under the VSDHOne infrastructure, signaling strong market demand.

A distinct feature of Hydreight's performance in 2025 was its transition from early-stage development to a scalable healthcare infrastructure. The national platform supports compliant patient access, prescribing, and fulfillment of services across all U.S. states, showcasing the company's commitment to broadening access to healthcare services.

Future Outlook and Expansion Plans

Looking ahead, Hydreight has publicly projected a revenue guidance of $150 million for fiscal 2026, bolstered by existing partner activity and visible market demand. However, the company cautioned stakeholders regarding potential risks and uncertainties that may affect these projections, ensuring that expectations remain grounded.

Victory Square has not only focused on scaling its existing healthcare platforms but has also ventured into the pet health sector through Pawsible Ventures. With the launch of a $10 million venture fund and initiatives for a pet health incubator, Victory Square is positioning itself to tap into the growing demand for veterinary diagnostics and digital care.

Commitment to Investors

Victory Square Technologies operates with a firm belief in transparency and value creation for its investors. The company’s model involves combining venture-style investing with operational involvement, ensuring that capital allocation aligns with long-term growth objectives. Shareholders recently received dividends from Yocale.ai, showcasing the company’s dedication to monetization through disciplined strategies.

In conclusion, Victory Square’s performance in fiscal 2025 paints a promising picture of growth and innovation within the healthcare and technology sectors. The scalable platforms and strategic investments made by the company set the stage for continued success. As it navigates through future challenges and opportunities, Victory Square remains committed to its mission of building robust infrastructures that drive meaningful healthcare solutions.

• ---

For further details and updates on the company's ventures and developments, visit Victory Square Technologies.